Carr Biosystems has acquired Alfa Wassermann. Together we support more separations across the bioprocessing workflow, from cell harvest and clarification through virus purification and concentration — backed by the service and support you rely on today.
Carr Biosystems designs and manufactures cell processing and separations systems for the life sciences industry. Its single- and multi-use centrifugation platforms help biopharmaceutical manufacturers process and purify cells and biologics. Carr was first to develop single-use continuous centrifugation and serves manufacturers worldwide across cell therapy, gene therapy, biologics, vaccines, microbial fermentation and cellular agriculture.
Alfa Wassermann Separation Technologies is a leader in the design, manufacture and service of continuous flow ultracentrifugation and fluid handling solutions, from process development through industrial-scale manufacturing. Its Promatix 1000, PKII and KII systems are trusted by leading pharmaceutical and biotechnology companies worldwide to produce vaccines, gene therapies and other biologics.
Get in touch with a sales representative, request support or download our free white paper.
Contact Us